Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30291735 | 0.87 | DRD1 (0.49) | DRD1HTR2A | |
| SCHEMBL9927296 | 0.87 | DRD1 (0.49) | DRD1HTR2A | |
| SCHEMBL16773716 | 0.80 | DRD1 (0.44) | DRD1AHRHTR2A | |
| SCHEMBL20516731 | 0.79 | DRD1 (0.42) | DRD1AHRHTR2A | |
| SCHEMBL31125706 | 0.79 | DRD1 (0.33) | DRD1AHR | |
| SCHEMBL47009 | 0.78 | ALOX5 (0.44) | DRD1AHRHTR2A | |
| SCHEMBL29360424 | 0.78 | ALOX5 (0.44) | DRD1AHRHTR2A | |
| SCHEMBL15982210 | 0.77 | DRD1 (0.41) | DRD1AHR | |
| SCHEMBL17856934 | 0.77 | DRD1 (0.41) | DRD1AHR | |
| Phosphine SCHEMBL17530281 | 0.76 | ALOX5 (0.42) | DRD1AHRHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150025280-A1 | LIGANDS FOR RHODIUM CATALYZED REDUCTIVE CARBONYLATION OF ALCOHOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-22 | — | — | US | disclosed |
| US-20150025280-A1 | LIGANDS FOR RHODIUM CATALYZED REDUCTIVE CARBONYLATION OF ALCOHOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-22 | — | — | US | disclosed |
| WO-2013096631-A1 | LIGANDS FOR RHODIUM CATALYZED REDUCTIVE CARBONYLATION OF ALCOHOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025280-A1 | LIGANDS FOR RHODIUM CATALYZED REDUCTIVE CARBONYLATION OF ALCOHOLS | ADH5, ADH1C, ADH1A | DRD1 873/4885AHR 747/4885ATM 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.